Your session is about to expire
← Back to Search
Nitric Oxide Donor
Nitric Oxide for Liver Cirrhosis
Phase 1
Waitlist Available
Research Sponsored by National Center for Research Resources (NCRR)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Cirrhotic patients with ascites with functional renal failure
Cirrhotic patient with ascites without renal failure
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
Study Summary
This trial is to see if nitric oxide affects blood pressure & kidney function in people with cirrhosis, compared to healthy subjects. 30 patients & 10 healthy subjects will be enrolled.
Who is the study for?
This trial is for adults with cirrhosis, a condition where the liver is scarred and doesn't work properly. It includes those with fluid buildup in the abdomen (ascites) but no kidney failure, as well as healthy individuals for comparison. People can't join if they have renal failure or other conditions not listed here.Check my eligibility
What is being tested?
The study investigates whether nitric oxide, a compound made by the body, affects blood pressure and kidney function in cirrhosis patients compared to healthy subjects. A total of 30 patients with cirrhosis and 10 healthy people will be enrolled.See study design
What are the potential side effects?
Since this trial seems to focus on observation rather than administering drugs or therapies directly related to nitric oxide levels, specific side effects are not detailed; however, general risks may include discomfort from testing procedures.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have cirrhosis with fluid in my abdomen and kidney issues.
Select...
I have cirrhosis with fluid in my abdomen but no kidney failure.
Select...
I have cirrhosis but have never had swelling or fluid build-up.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
National Center for Research Resources (NCRR)Lead Sponsor
537 Previous Clinical Trials
317,016 Total Patients Enrolled
4 Trials studying Liver Cirrhosis
436 Patients Enrolled for Liver Cirrhosis
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have cirrhosis with fluid in my abdomen and kidney issues.I have cirrhosis with fluid in my abdomen but no kidney failure.I have cirrhosis but have never had swelling or fluid build-up.I am healthy and my age and sex match the study's requirements.
Research Study Groups:
This trial has the following groups:Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What adverse risks are associated with this treatment?
"The pre-existing data on this treatment's efficacy and safety is sparse, so it earned a scored of 1."
Answered by AI
Is there an age ceiling for joining this analysis?
"Prospective participants in this trial must be between the ages of 18 and 70. Concurrently, there are 76 studies for those younger than eighteen years old and 428 that cater to senior citizens over 65."
Answered by AI
Who else is applying?
What site did they apply to?
4200 E. Ninth Ave., Box C281
What portion of applicants met pre-screening criteria?
Did not meet criteria
Share this study with friends
Copy Link
Messenger